Fantini Massimo C, Dominitzki Sabine, Rizzo Angelo, Neurath Markus F, Becker Christoph
Division of Gastroenterology, University of Rome Tor Vergata, Via Montpellier 1, 00133, Rome, Italy.
Nat Protoc. 2007;2(7):1789-94. doi: 10.1038/nprot.2007.258.
CD4+ CD25+ regulatory T cells (Tregs) are crucial for the maintenance of immunological tolerance. Recent data indicate that Tregs not only develop in the thymus during ontogeny but can also differentiate from naive T cells in the periphery. The following protocol describes a method by which Tregs are generated in vitro by stimulation of naive T cells in the presence of transforming growth factor beta (Ti-Tregs). In vitro-induced regulatory T cells express markers of conventional Treg such as CD25 and the genetic program committing transcription factor FoxP3. Functionally the in vitro-generated Ti-Tregs suppress T-cell activation and proliferation while in vivo these cells have been proven to control inflammation in different animal models, suggesting a potential use of these cells for immunotherapy. The protocol can be completed within 5 days.
CD4+ CD25+ 调节性T细胞(Tregs)对于维持免疫耐受至关重要。最近的数据表明,Tregs不仅在个体发育过程中于胸腺中发育,还可在外周从初始T细胞分化而来。以下方案描述了一种在转化生长因子β存在的情况下通过刺激初始T细胞在体外生成Tregs的方法(Ti-Tregs)。体外诱导的调节性T细胞表达常规Treg的标志物,如CD25以及决定转录因子FoxP3的遗传程序。在功能上,体外生成的Ti-Tregs抑制T细胞活化和增殖,而在体内,这些细胞已被证明可在不同动物模型中控制炎症,这表明这些细胞在免疫治疗方面具有潜在用途。该方案可在5天内完成。